Repository logo
 

The social dimension of apathy: evidence for a distinct domain from 11,243 individuals across health and neurocognitive disorders.

Published version
Peer-reviewed

Repository DOI


Change log

Abstract

Apathy is a highly prevalent and disabling neuropsychiatric syndrome, but its multi-dimensional structure is a challenge for progress towards better identification and treatment. A crucial unresolved question is whether social disengagement reflects a distinct deficit in social motivation or a by-product of diminished initiative or emotional blunting. Previous studies have been constrained by modest sample sizes and limited use of apathy-specific instruments or phenotypically narrow cohorts. Here, we analysed item-level data from 11,243 individuals recruited across multiple centres, including 1154 neurological patients with Alzheimer's disease, Parkinson's disease, frontotemporal dementia, autoimmune encephalitis and small vessel disease, alongside people with depression and healthy adults. Across exploratory and confirmatory factor analyses, symptom-level network modelling, and lifespan analyses, social apathy consistently emerged as a coherent and separable dimension. This pattern was preserved across health, psychiatric, and neurocognitive cohorts, from adolescence through late life. Recognising social apathy as an independent domain reframes a central aspect of mental health-the motivation to connect, care, and act for others-and provides a foundation for more precise assessment and for interventions targeting both social and neurobiological mechanisms.

Description

Acknowledgements: This work was supported by the Wellcome Trust and the National Institute for Health Research (NIHR) Oxford Health Biomedical Research Centre. S.Z., S.T., M.J.B., and M.H. are funded by the Wellcome Trust [226645/Z/22/Z]. S.T., S.G.M. and M.H. are funded by and the NIHR Oxford Health BRC. S.G.M. is also supported by the NIHR Oxford BRC. J.B.R. is supported by the Medical Research Council [MC_UU_00030/14; SUAG/092 G116768], the Wellcome Trust [220258], the NIHR Cambridge Biomedical Research Centre [NIHR203312], and the Holt Fellowship. S.R.I. is supported by a Senior Clinical Fellowship from the Medical Research Council [MR/V007173/1], a Wellcome Trust Fellowship [104079/Z/14/Z], the Kogod Centre on Aging (Mayo Clinic), and the NIHR Oxford Biomedical Research Centre. R.Y. is supported by the National Natural Science Foundation of China [82171917, 82471271, U23A20424], the Anhui Provincial Natural Science Foundation [2408085Y047], and the Natural Science Research Project of Anhui Educational Committee [2023AH050592]. Q.Y.T. was funded by Guangdong and Hong Kong Universities “1 + 1 + 1” Joint Research Collaboration Scheme (2025A0505000011). C.L.H. is supported by a grant from the Canterbury Medical Research Foundation [02/2019]. B.A. is supported by an NIHR Academic Clinical Lectureship. We gratefully acknowledge all the participants, their families, and the staff at the Cognitive Disorders Clinic and the Autoimmune Neurology Clinic at John Radcliffe Hospital, Addenbrooke’s Hospital, St George’s Hospital, the New Zealand Brain Research Institute and the China Parkinson’s Disease Advanced Center for their dedication to this programme. The views expressed are those of the author(s) and not necessarily those of the NHS, the NIHR, or the Department of Health and Social Care.


Publication status: Published


Funder: R.Y. is supported by the National Natural Science Foundation of China [82171917, 82471271, U23A20424], the Anhui Provincial Natural Science Foundation [2408085Y047], and the Natural Science Research Project of Anhui Educational Committee [2023AH050592].


Funder: Guangdong–Hong Kong Universities “1+1+1” Joint Funding Programme


Funder: NIHR Academic Clinical Lectureship


Funder: NIHR Oxford Health BRC, NIHR Oxford BRC


Funder: Senior Clinical Fellowship from the Medical Research Council [MR/V007173/1], a Wellcome Trust Fellowship [104079/Z/14/Z], the Kogod Centre on Aging (Mayo Clinic), and the NIHR Oxford Biomedical Research Centre


Funder: J.B.R. is supported by the Medical Research Council [MC_UU_00030/14; SUAG/092 G116768], the Wellcome Trust [220258], the NIHR Cambridge Biomedical Research Centre [NIHR203312], and the Holt Fellowship.

Journal Title

Transl Psychiatry

Conference Name

Journal ISSN

2158-3188
2158-3188

Volume Title

16

Publisher

Springer Nature

Rights and licensing

Except where otherwised noted, this item's license is described as http://creativecommons.org/licenses/by/4.0/
Sponsorship
Wellcome Trust (220258/Z/20/Z)
MRC (MC_UU_00030/14)